Collagen crosslinking with riboflavin is a treatment used to manage keratoconus, a progressive condition where the cornea becomes thin and irregularly shaped. The procedure involves applying riboflavin (vitamin B2) to the cornea, followed by exposure to ultraviolet (UV) light. This process strengthens the collagen fibers in the cornea, making it more rigid and stable, preventing further deterioration of the corneal shape.

Collagen crosslinking is performed as a non-invasive procedure under local anesthesia. It has been shown to halt or slow the progression of keratoconus, improving corneal strength and reducing the need for corneal transplants. The treatment is most effective when performed in the early to moderate stages of the disease.

This procedure provides an excellent option for patients with keratoconus who want to avoid more invasive surgeries and maintain better visual outcomes. The recovery time is relatively short, and patients typically experience minimal discomfort post-procedure.